ISOPTO CARPINE 4% price in UAE

Overview

Welcome to Dwaey, specifically on ISOPTO CARPINE 4% Eye Drops page.
This medicine contains an important and useful components, as it consists of Pilocarpine HCl.
ISOPTO CARPINE 4% is available in the market in concentration 40mg/ml and in the form of Eye Drops.

ALCON-COUVREUR S.A. is the producer of ISOPTO CARPINE 4% and it is imported from BELGIUM, The most popular alternatives of ISOPTO CARPINE 4% are listed downward .

Mode Of Action

Pilocarpine is a tertiary parasympathomimetic that directly stimulates cholinergic receptors in the eyes causing pupillary constriction, spasm of accommodation and a transient rise in IOP followed by a fall.

Indication

Dry mouth
Sjogren's syndrome

Precaution

CVD, cholelithiasis, biliary tract dz, COPD, chronic bronchitis, concomitant use of beta adrenergic agonist, renal insufficiency, PUD, Parkinson's, hyperthyroidism, urinary tract obstruction Lactation: unknown if drug is distributed into breast milk; use caution

Side Effects

>10% Sweating (29%)
Headache (15%)
Flushing (8-13%)
Chills (3-15%) 1-10% Nervousness (10%)
Nausea (6%)
Dizziness (>3%)
Asthenia (>3%) Frequency Not Defined Confusion
Hypotension
Hypertension
Bradycardia
Tachycardia
Increased airway resistance
Abdominal cramping
Diarrhea
Urinary frequency
Bladder tightness
Decreased visual acuity

Contra indication

Angle-closure glaucoma; acute iritis, anterior uveitis; hypersensitivity. Pregnancy.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Concomitant admin of 2 miotics may increase risk of toxic reactions. Aminoglycosides, clindamycin, colistin, cyclopropane and halogenated inhalational anaesthetics, quinine, procainamide, lithium and beta-blockers may reduce the efficacy of pilacarpine. Concurrent use with beta-blockers may lead to bradycardia. May prolong the action of suxamethonium. Potentially Fatal: Miotic and ocular hypotensive effect antagonised by anticholinergics. Conduction disturbances with beta-blockers.